U.S. Energy Services Stock News

UiPath (PATH) just posted its FY 2026 Q4 scorecard with revenue of US$481.1 million and basic EPS of US$0.19, alongside net income of US$104.5 million, putting a clear spotlight on how its automation platform is now feeding through to the bottom line. The company has seen quarterly revenue move from US$354.7 million in FY 2025 Q3 to US$423.6 million in FY 2025 Q4, then to US$356.6 million, US$361.7 million, US$411.1 million and now US$481.1 million in FY 2026 Q4. Basic EPS over those same...

Abacus Global Management, Inc. reported past fourth-quarter 2025 revenue of US$71.9 million, up from US$33.21 million a year earlier, and turned a prior net loss of US$18.26 million into net income of US$7.23 million, with basic earnings per share from continuing operations improving from a loss of US$0.22 to earnings of US$0.07. For 2025 as a whole, the company’s revenue more than doubled to US$235.24 million and it moved from a full-year net loss of US$23.96 million to net income of...

BK Technologies (BKTI) just posted fourth quarter FY 2025 revenue of US$21.5 million with basic EPS of US$1.12, alongside trailing 12 month revenue of US$86.1 million and EPS of US$3.69 that reflect the broader run rate coming into this report. The company has seen revenue move from US$17.9 million in Q4 2024 to US$21.5 million in Q4 2025, with basic EPS shifting from US$1.03 to US$1.12 over the same period, setting up a picture of earnings that feed into trailing 12 month net income of...

Magnolia Oil & Gas (NYSE:MGY) has reported significant growth in its proved developing producing reserves. The company also highlighted continued increases in production levels. This operational update focuses on changes in Magnolia's resource base and output profile, rather than on valuation or analyst forecasts. For investors tracking NYSE:MGY, this reserve and production update adds fresh operational context to a share price that most recently closed at $28.94. The stock has returned...

If you are wondering whether Mueller Water Products at about US$27.62 is offering fair value or a potential bargain, looking at how the stock is priced against its fundamentals can help you frame that question more clearly. The share price has eased in the short term, with a 4.5% decline over 7 days and a 6.2% decline over 30 days, while still sitting on a 15.4% gain year to date and a 6.1% return over the past year. These moves sit against a backdrop of ongoing interest in water...

Matson announced the upcoming retirement of Executive Vice President and Chief Commercial Officer John Lauer and named Chris Scott as his successor. The company outlined additional leadership promotions connected to this transition. Matson also launched a new cargo security initiative with BNSF Railway and War-Lok, adding multiple layers of protection for international intermodal cargo. Matson (NYSE:MATX) is pairing major leadership changes with an operational shift in how it protects...

LCNB (LCNB) closed out FY 2025 with fourth quarter revenue of US$22.3 million and basic EPS of US$0.40, while trailing twelve month figures showed revenue of US$90.1 million and EPS of US$1.63 as the bank reported net income of US$23.0 million over the period. Over recent reporting periods, revenue has moved from US$79.2 million and EPS of US$0.97 on a trailing basis at the end of 2024 to US$90.1 million and EPS of US$1.63 by the end of 2025, highlighting a period where net margins and...

Gambling.com Group (GAMB) closed FY 2025 with Q4 revenue of US$46.2 million and a basic EPS loss of US$0.77, alongside a trailing twelve month basic EPS loss of US$0.93 on revenue of US$165.4 million. The company has seen quarterly revenue move from US$35.3 million and basic EPS of US$0.23 in Q4 2024 to US$46.2 million with a basic EPS loss of US$0.77 in Q4 2025, while trailing twelve month revenue shifted from US$127.2 million with basic EPS of US$0.85 in Q4 2024 to US$165.4 million with a...

Century Therapeutics (IPSC) just posted FY 2025 results that put revenue at US$109.2 million with basic EPS of US$0.51 for the latest half, against a trailing twelve month profile that still shows a loss, with EPS of US$0.11 and net income of US$9.6 million in the red on US$109.2 million of revenue. Over the past year, the company has reported revenue of US$1.6 million and EPS of US$0.82 in early 2024, then US$4.96 million with EPS of US$0.79 in the second half of 2024, and then the latest...

ProFrac Holding (ACDC) closed out FY 2025 with fourth quarter revenue of US$436.5 million and a basic EPS loss of US$0.79, alongside net income excluding extra items of a US$142.6 million loss. Over the past few quarters, the company has seen revenue move from US$600.3 million and a basic EPS loss of US$0.12 in Q1 2025 to US$403.1 million and a basic EPS loss of US$0.60 in Q3 2025. Trailing twelve month figures show revenue at US$1.9 billion and a net loss of US$369 million, setting up a...

Viant Technology (DSP) just closed out FY 2025 with fourth quarter revenue of US$110.1 million and basic EPS of US$0.49, alongside trailing 12 month revenue of US$344.2 million and EPS of US$0.51 that sit against a net profit margin of 2.4%. Over the past few quarters the company has seen revenue move from US$70.6 million in Q1 2025 to US$110.1 million in Q4 2025, with basic EPS ranging from a loss of US$0.07 in Q1 2025 to US$0.49 in Q4 2025. This gives investors a clearer view of how the...

CareCloud (CCLD) has capped FY 2025 with fourth quarter revenue of US$34.4 million and basic EPS of US$0.04, alongside trailing 12 month revenue of US$120.5 million and basic EPS of US$0.10, marking a clean move away from the losses seen earlier in the period. The company has seen quarterly revenue step up from US$27.4 million in Q2 2025 to US$34.4 million in Q4 2025, while quarterly basic EPS has shifted from a loss of US$0.04 in Q1 2025 to positive readings in each subsequent quarter,...

Trinity Capital (NasdaqGS:TRIN) has recently committed growth capital to three MedTech companies: Monteris Medical, Emboline, and Neuros Medical. The financing supports commercialization of Monteris Medical's neurosurgical system, Emboline's heart procedure protection platform, and Neuros Medical's non opioid pain treatment device. These back to back commitments expand Trinity Capital's exposure to advanced medical technologies within its venture lending portfolio. Trinity Capital focuses...

In its latest reported quarter, Armstrong World Industries posted 5.6% year-on-year revenue growth and record quarterly and full-year sales and earnings, but both revenue and adjusted operating income came in about 3% below analysts’ estimates. This combination of record performance and shortfalls versus expectations highlights how market sentiment can hinge more on forecasts and relative performance than on headline growth alone. Next, we’ll examine how record results coupled with...

Voyager Therapeutics, Inc. recently reported fourth-quarter 2025 results showing a net loss of US$27.43 million, improving from US$34.49 million a year earlier, while its full-year 2025 net loss widened to US$119.72 million from US$65.00 million in 2024. Although Voyager reduced its quarterly loss per share, the much larger full-year loss highlights the cost intensity of advancing its neurological disease pipeline. We’ll now examine how Voyager’s improved quarterly loss but much larger...

Zurn Elkay Water Solutions (NYSE:ZWS) reported record annual performance with double digit core sales growth. The company highlighted improved operating margins over the year. Management announced a substantial increase in its dividend. The company also disclosed a significant share repurchase program. Zurn Elkay Water Solutions focuses on water management products and systems, an area that sits at the intersection of infrastructure, building construction, and resource efficiency. With...

Digimarc (DMRC) has just posted its FY 2025 numbers, with Q4 revenue of US$8.9 million, a basic EPS loss of US$0.19, and net income excluding extra items showing a loss of US$4.2 million, setting the tone for how investors will read the full year. Over recent quarters, the company has seen revenue move between US$7.6 million and US$9.4 million while quarterly EPS losses ranged from US$0.19 to US$0.55, giving a clear picture of a business that is still loss making but working through its cost...

If you are wondering whether BioNTech's current share price lines up with its long term potential, starting with a clear look at valuation can help you frame that question more calmly. BioNTech's shares recently closed at US$90.10, with returns of 11.6% decline over the past week, 17.3% decline over the last month, and 6.8% decline year to date, alongside 7.6% decline over 1 year, 31.7% decline over 3 years, and 12.2% decline over 5 years, which hints that the market's view on risk and...

Montauk Renewables (MNTK) closed out FY 2025 with Q4 revenue of US$43.4 million and basic EPS of US$0.02 on net income of US$2.5 million, setting the tone for a year where reported earnings and margins were under close watch. The company has seen quarterly revenue move from US$27.7 million and basic EPS of US$0.06 in Q4 2024 to a mix of losses and profits through 2025, including Q2 revenue of US$45.1 million with a loss of US$5.5 million and basic EPS of US$0.04, before landing on US$45.3...

Velocity Financial FY 2025 results in focus Velocity Financial (VEL) has wrapped up FY 2025 with fourth quarter total revenue of US$57.1 million and basic EPS of US$0.89, setting the tone for how investors will read the full year. The company has seen quarterly revenue move from US$84.9 million in Q4 2024 to US$57.1 million in Q4 2025, while basic EPS shifted from US$0.62 to US$0.89 over the same period, and on a trailing twelve month basis EPS stands at US$2.81 on revenue of US$183.5...

Oil-Dri Corporation of America (ODC) has just posted Q2 2026 results with revenue of US$117.7 million and basic EPS of US$0.87, alongside trailing twelve month EPS of US$3.62 on revenue of US$478.9 million. Over recent quarters the company has seen revenue move between US$116.9 million and US$127.9 million, while quarterly EPS has ranged from US$0.80 to US$1.13. This sets up a picture of steady top line and earnings performance that now sits on the back of 15.6% earnings growth over the past...

Sleep Number (SNBR) has capped FY 2025 with fourth quarter revenue of US$347.4 million and a basic EPS loss of US$2.55, as net income excluding extra items came in at a loss of US$58.5 million. The company has seen quarterly revenue move from US$393.3 million in Q1 2025 to US$327.9 million in Q2, US$342.9 million in Q3 and US$347.4 million in Q4, alongside a widening basic EPS loss over the same stretch. For investors, that mix of steady sales levels and deeper losses keeps the focus firmly...

Frequency Electronics (FEIM) has just posted Q3 2026 results with revenue of US$16.9 million, basic EPS of US$0.16 and net income of US$1.6 million. This comes in a year where trailing 12 month revenue sits at US$67.8 million and EPS at US$0.74. Over recent quarters the company has seen revenue move from US$18.9 million in Q3 2025 to US$19.0 million in Q4 2025, then US$13.8 million, US$17.1 million and now US$16.9 million. Basic EPS shifted from US$1.60 to US$0.33, US$0.07, US$0.18 and...

Q32 Bio (QTTB) has just posted its FY 2025 numbers, reporting fourth quarter revenue of US$53.7 million and basic EPS of US$4.60, alongside trailing 12 month basic EPS of US$2.42 and net income of US$29.8 million. The company’s quarterly revenue has moved from US$0 and a basic EPS loss of US$1.16 in Q4 2024 to US$53.7 million and US$4.60 in Q4 2025. Interim 2025 quarters showed no revenue and basic EPS losses between US$0.60 and US$0.90, so investors will likely focus on how durable these...